Molecular Medicine | Home
molmed.biomedcentral.comMolecular Medicine is an open access journal publishing recent findings that elucidate disease pathogenesis at the molecular or physiological level, which may lead to the design of specific tools for disease diagnosis, treatment, or prevention. Manuscripts containing material relevant to the genetic, molecular, or cellular basis of key physiologic or disease processes are considered for publication.
Molecular Medicine Impact Factor IF 2021|2020|2019 - BioxBio
www.bioxbio.com › journal › MOL-MEDMolecular Medicine strives to understand normal body functioning and disease pathogenesis at the molecular level which may allow researchers and physician-scientists to use that knowledge in the design of specific molecular tools for disease diagnosis, treatment, prognosis, and prevention. Manuscripts submitted to the journal should maintain this focus and describe the implications for human disease, at a level approachable by the broad readership of Molecular Medicine.
EMBO Molecular Medicine
www.embopress.org › journal › 17574684Jan 13, 2022 · A lentiviral vector-based vaccine, used in prime and intranasal boost, induces strong B- and T-cell immunity. This vaccine candidate protects against both pulmonary and neurological COVID-19 caused by either ancestral or emerging SARS-CoV-2. Article 17 November 2021 OPEN ACCESS.
EMBO reports
www.embopress.org › journal › 14693178Dec 06, 2021 · Volume 22 Issue 12. 6 December 2021. In this issue submit a manuscript sign up for alerts. During aging, telomere dysfunction accumulates and activates a DNA damage response, leading to increase of ACE2, the human SARS-CoV-2 receptor. This mechanism may explain the higher susceptibility of elderly to COVID-19.